Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Radioimmunotherapy In Relapsed/Refractory Mantle Cell Lymphoma Patients: Final Results Of a European MCL Network Phase II Trial

Simone Ferrero, Alessandro Pastore, Roswitha Forstpointner, M.D., Christian W. Scholz, Antonio Pezzutto, Lothar Bergmann, Lorenz Truemper, Juergen Finke, Ulrich Keller, Marco Ladetto, Wolfgang Hiddemann, M.D., Oliver Weigert, Michael Unterhalt, Martin Dreyling

Blood (2013) 122 (21): 4384.

https://doi.org/10.1182/blood.V122.21.4384.4384

Published: 2013

Journal Articles

Pseudo-Exhaustion Of CD8 + T Cells in AML

Felix S. Lichtenegger, MD, Frauke M. Schnorfeil, PhD, Katharina Emmerig, Julia S. Neitz, Barbara Beck, PhD, Rika Draenert, MD, Wolfgang Hiddemann, M.D., Marion Subklewe, MD

Blood (2013) 122 (21): 2615.

https://doi.org/10.1182/blood.V122.21.2615.2615

Published: 2013

Journal Articles

Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia

TILL M SEILER, MD, Roland Aydin, Tobias Herold, MD, Stefan Holdenrieder, MD, Michael Hallek, M.D. Ph.D., Wolfgang Hiddemann, M.D., Martin Dreyling, Manuela A. Bergmann, MD

Blood (2013) 122 (21): 1619.

https://doi.org/10.1182/blood.V122.21.1619.1619

Published: 2013

Journal Articles

High Efficiency Of the PDPK1-Inhibitor, BX912, In MCL

Grit Hutter, Yvonne Zimmermann, Vladimir Giller, Anna-Katharina Zoellner, Oliver Weigert, Wolfgang Hiddemann, M.D., Martin Dreyling

Blood (2013) 122 (21): 3077.

https://doi.org/10.1182/blood.V122.21.3077.3077

Published: 2013

Journal Articles

Improving Efficacy of Dendritic Cell Vaccination in AML: Optimization of the DC Generation Protocol and Maximization of T Cell Responses by Immune Checkpoint Blockade

Felix S Lichtenegger, MD, Barbara Beck, PhD, Christiane Geiger, PhD, Dieter Munker, Miriam Schlueter, Rika Draenert, MD, Frauke Schnorfeil, PhD, Gunnar Kvalheim, MD, PhD, Wolfgang Hiddemann, M.D., Dolores J Schendel, PhD, Marion Subklewe, MD

Blood (2013) 122 (21): 3492.

https://doi.org/10.1182/blood.V122.21.3492.3492

Published: 2013

Journal Articles

Bifunctional Immunoactive siRNAs as an Approach to Personalized AML Therapy

Hanna Meinl, Marcus Zeitlhöfler, Samet Kocabey, Tim Liedl, PhD, Wolfgang Hiddemann, M.D., Marion Subklewe, MD, Stefan Endres, MD, Simon Rothenfußer, MD, Felix S Lichtenegger, MD

Blood (2013) 122 (21): 5036.

https://doi.org/10.1182/blood.V122.21.5036.5036

Published: 2013

Journal Articles

Coinhibitory Expression Profiling of AML Blasts Identifies HVEM as Prognostic Marker in AML

Felix S Lichtenegger, MD, Isabell Kondla, Michael Krempasky, Anna L Weber, Stephanie Schneider, PhD, Karsten Spiekermann, MD, Jan Braess, MD, Wolfgang Hiddemann, M.D., Marion Subklewe, MD

Blood (2013) 122 (21): 1359.

https://doi.org/10.1182/blood.V122.21.1359.1359

Published: 2013

Journal Articles

Genetic Profiling By Targeted, Deep Resequencing Confirms That a Murine Xenograft Model Of Acute Myeloid Leukemia (AML) Recapitulates The Mutational Landscape Of The Human Disease and Provides Evidence For Clonal Heterogeneity and Clonal Evolution

Maja Rothenberg-Thurley, Dr., Binje Vick, Dr., Stephanie Schneider, PhD, Bianka Ksienzyk, Philipp A Greif, MD, Michael Fiegl, MD, Marion Subklewe, MD, Wolfgang Hiddemann, M.D., Karsten Spiekermann, MD, Irmela Jeremias, MD, Klaus H. Metzeler, MD

Blood (2013) 122 (21): 49.

https://doi.org/10.1182/blood.V122.21.49.49

Published: 2013

Journal Articles

Evaluation Of Myeloablative Therapy Followed By Autologous Stem Cell Transplantation In First Remission In Patients With Advanced Stage Follicular Lymphoma After Initial Immuno-Chemotherapy (R-CHOP) Or Chemotherapy Alone: Analysis Of 940 Patients Treated In Prospective Randomized Trials Of The German Low Grade Lymphoma Study Group (GLSG)

Wolfgang Hiddemann, M.D., Martin H. Dreyling, M.D. Ph.D., Bernd Metzner, M.D., Michael Pfreundschuh, M.D. Ph.D., Martin Wilhelm, M.D. Ph.D., Eva Lengfelder, M.D. Ph.D., Georg Hess, M.D. Ph.D., Michael Hallek, M.D. Ph.D., Norbert Schmitz, M.D. Ph.D., Christiane Pott, M.D. Ph.D., Thomas Fischer, M.D. Ph.D., Roswitha Forstpointner, M.D., Eva Hoster, Ph.D., Michael Unterhalt, M.D. Ph.D.

Blood (2013) 122 (21): 419.

https://doi.org/10.1182/blood.V122.21.419.419

Published: 2013

Journal Articles

Ectopic Expression of CDX2 Perturbs HOX Gene Expression in Murine Progenitors Depending on Its N-Terminal Transactivation Domain and Is Closely Correlated with Deregulated HOX Gene Expression in Human Acute Myeloid Leukemia.

Vijay P.S. Rawat, PhD, Silvia Thoene, M.Sc, Vegi M. Naidu, M.Sc, Natalia Arseni, Ph.D., Bernhard Heilmeier, M.D., Klaus Metzeler, M.D., Konstantin Petropoulos, M.Sc, Aniruddha Deshpande, Ph.D., Leticia Quintanilla-Martinez, M.D., Stefan Bohlander, M.D., Karsten Spiekermann, M.D., Wolfgang Hiddemann, M.D., Michaela Feuring-Buske, M.D., Christian Buske, M.D.

Blood (2007) 110 (11): 2125.

https://doi.org/10.1182/blood.V110.11.2125.2125

Published: 2007

Journal Articles

The Vent-Like Homeobox Gene VENTX2 Is Expressed in Human Hematopoietic Progenitor Cells and Promotes Human Myeloid Development In Vitro and In Vivo.

Natalia Arseni, PhD, Farid Ahmed, Ph.D., Vijay P.S. Rawat, Ph.D., Timothy J. Sadlon, M.D., Wolfgang Hiddemann, M.D., Christian Buske, M.D., Michaela Feuring-Buske, M.D.

Blood (2007) 110 (11): 1275.

https://doi.org/10.1182/blood.V110.11.1275.1275

Published: 2007

Journal Articles

Pegylated Recombinant G-CSF after Sequential High Dose Cytarabine Based Induction Chemotherapy in AML - Analysis of Pharmakokinetics and Effect on Neutrophil Recovery of Pegfilgrastim.

Michael A. Fiegl, MD, Wolfgang Hiddemann, M.D., Ph.D., Jan Braess, M.D., Ph.D.

Blood (2006) 108 (11): 4551.

https://doi.org/10.1182/blood.V108.11.4551.4551

Published: 2006

Journal Articles

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 2025.

https://doi.org/10.1182/blood.V104.11.2025.2025

Published: 2004

Journal Articles

Identification of Biologically Distinct and Clinically Relevant Subentities in Patients with Acute Myeloid Leukemia and Normal Karyotypes by Use of Gene Expression Profiling.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Alexander Kohlmann, Ph.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 195.

https://doi.org/10.1182/blood.V104.11.195.195

Published: 2004

Journal Articles

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 4776.

https://doi.org/10.1182/blood.V104.11.4776.4776

Published: 2004

Journal Articles

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 2376.

https://doi.org/10.1182/blood.V104.11.2376.2376

Published: 2004

Journal Articles

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 400.

https://doi.org/10.1182/blood.V104.11.400.400

Published: 2004

Journal Articles

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Torsten Haferlach, M.D., Daniela Voskova, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D.

Blood (2004) 104 (11): 319.

https://doi.org/10.1182/blood.V104.11.319.319

Published: 2004

Journal Articles

Gene Expression Profiling in Adult Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, and Acute Myeloid Leukemia M0: Confirmation of Immunophenotypic and Cytogenetic Diagnostic Findings.

Wolfgang Kern, M.D., Alexander Kohlmann, Claudia Schoch, M.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 993.

https://doi.org/10.1182/blood.V104.11.993.993

Published: 2004

Journal Articles

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Blood (2004) 104 (11): 871.

https://doi.org/10.1182/blood.V104.11.871.871

Published: 2004

NARROW

Radioimmunotherapy In Relapsed/Refractory Mantle Cell Lymphoma Patients: Final Results Of a European MCL Network Phase II Trial

Pseudo-Exhaustion Of CD8 + T Cells in AML

Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia

High Efficiency Of the PDPK1-Inhibitor, BX912, In MCL

Improving Efficacy of Dendritic Cell Vaccination in AML: Optimization of the DC Generation Protocol and Maximization of T Cell Responses by Immune Checkpoint Blockade

Bifunctional Immunoactive siRNAs as an Approach to Personalized AML Therapy

Coinhibitory Expression Profiling of AML Blasts Identifies HVEM as Prognostic Marker in AML

Genetic Profiling By Targeted, Deep Resequencing Confirms That a Murine Xenograft Model Of Acute Myeloid Leukemia (AML) Recapitulates The Mutational Landscape Of The Human Disease and Provides Evidence For Clonal Heterogeneity and Clonal Evolution

Ectopic Expression of CDX2 Perturbs HOX Gene Expression in Murine Progenitors Depending on Its N-Terminal Transactivation Domain and Is Closely Correlated with Deregulated HOX Gene Expression in Human Acute Myeloid Leukemia.

The Vent-Like Homeobox Gene VENTX2 Is Expressed in Human Hematopoietic Progenitor Cells and Promotes Human Myeloid Development In Vitro and In Vivo.

Pegylated Recombinant G-CSF after Sequential High Dose Cytarabine Based Induction Chemotherapy in AML - Analysis of Pharmakokinetics and Effect on Neutrophil Recovery of Pegfilgrastim.

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Identification of Biologically Distinct and Clinically Relevant Subentities in Patients with Acute Myeloid Leukemia and Normal Karyotypes by Use of Gene Expression Profiling.

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Gene Expression Profiling in Adult Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, and Acute Myeloid Leukemia M0: Confirmation of Immunophenotypic and Cytogenetic Diagnostic Findings.

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only